RMIT University
Browse

A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations

journal contribution
posted on 2024-11-01, 16:40 authored by Michael Roche, Hamid Salimi, Renee Duncan, Brendan Wilkinson, Kelechi Chikere, Miranda Moore, Nicholas Webb, Helena Zappi, Jasminka Sterjovski, Jacqueline Flynn, Anne Ellett, Lachlan Gray, Benhur Lee, Becky Jubb, Mike Westby, Paul RamslandPaul Ramsland, Sharon Lewin, Richard Payne, Melissa ChurchillMelissa Churchill, Paul Gorry
No description available

History

Related Materials

  1. 1.
    DOI - Is published in 10.1186/1742-4690-10-43
  2. 2.
    ISSN - Is published in 17424690

Journal

Retrovirology

Volume

10

Number

43

Issue

1

Start page

1

End page

20

Total pages

20

Publisher

BioMed Central

Place published

United Kingdom

Language

English

Copyright

© 2013 Roche et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Former Identifier

2006050362

Esploro creation date

2020-06-22

Fedora creation date

2015-09-29

Usage metrics

    Scholarly Works

    Categories

    Keywords

    CCR5 ECLsCCR5 N-terminusEnvHIV-1MaravirocResistanceV3 loopgp120

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC